(Q37724856)

22 August 2017

1 reference

title

Assessment of mucosal immunity to HIV-1. (English)

1 reference

22 August 2017

0 references

Christiane Stahl-Hennig

6

Christiane Stahl-Hennig

1 reference

22 August 2017

Anna-Lena Spetz

13

0 references

Jorma Hinkula

Jorma Hinkula

3

0 references

Donata Medaglini

Donata Medaglini

4

0 references

Robin Shattock

12

Robin J Shattock

1 reference

22 August 2017

1

Vicky Jespers

1 reference

22 August 2017

11

Martin Cranage

1 reference

22 August 2017

Ali M Harandi

2

1 reference

22 August 2017

Roger Le Grand

5

1 reference

22 August 2017

Willy Bogers

7

1 reference

22 August 2017

Raphaelle El Habib

8

1 reference

22 August 2017

Frank Wegmann

9

1 reference

22 August 2017

Carol Fraser

10

1 reference

22 August 2017

publication date

1 April 2010

1 reference

Expert Review of Vaccines

22 August 2017

published in

1 reference

22 August 2017

volume

9

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

381-394

1 reference

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

22 August 2017

cites work

1 reference

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles

21 January 2018

1 reference

Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women

21 January 2018

1 reference

Mucosal HIV-binding antibody and neutralizing activity in high-risk HIV-uninfected female participants in a trial of HIV-vaccine efficacy.

21 January 2018

1 reference

Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety

21 January 2018

1 reference

Understanding basic mechanisms and optimizing assays to evaluate the efficacy of vaginal microbicides

21 January 2018

1 reference

An African perspective on mucosal immunity and HIV-1.

21 January 2018

1 reference

Setting the stage: host invasion by HIV.

21 January 2018

1 reference

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.

21 January 2018

1 reference

21 January 2018

Toward an AIDS vaccine

1 reference

Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women

21 January 2018

1 reference

Not just sheer luck! Immune correlates of protection against HIV-1 infection.

21 January 2018

1 reference

Cervical HIV-specific IgA in a population of commercial sex workers correlates with repeated exposure but not resistance to HIV.

21 January 2018

1 reference

The immune response during acute HIV-1 infection: clues for vaccine development

21 January 2018

1 reference

Protective vaccination against genital herpes simplex virus type 2 (HSV-2) infection in mice is associated with a rapid induction of local IFN-gamma-dependent RANTES production following a vaginal viral challenge

21 January 2018

1 reference

Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes

21 January 2018

1 reference

Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.

21 January 2018

1 reference

CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides

21 January 2018

1 reference

Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus

21 January 2018

1 reference

Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts

21 January 2018

1 reference

Comparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopes

21 January 2018

1 reference

Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope.

21 January 2018

1 reference

Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site

21 January 2018

1 reference

Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site

21 January 2018

1 reference

Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments

21 January 2018

1 reference

Mucosal administration of three recombinant Mycobacterium bovis BCG-SIVmac251 strains to cynomolgus macaques induces rectal IgAs and boosts systemic cellular immune responses that are primed by intradermal vaccination.

21 January 2018

1 reference

The immune geography of IgA induction and function

21 January 2018

1 reference

Longitudinal analysis of CD8(+) T-cell phenotype and IL-7, IL-15 and IL-16 mRNA expression in different tissues during primary simian immunodeficiency virus infection.

21 January 2018

1 reference

Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid

21 January 2018

1 reference

Six-day randomized safety trial of intravaginal lime juice

21 January 2018

1 reference

Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study

21 January 2018

1 reference

Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study

21 January 2018

1 reference

Correlates of IL-10 and IL-12 concentrations in cervical secretions

21 January 2018

1 reference

Determinants and correlation of systemic and cervical concentrations of total IgA and IgG.

21 January 2018

1 reference

Neutralizing antibodies in mucosal secretions: IgG or IgA?

21 January 2018

1 reference

Women in the Netherlands prefer self-sampling with a novel lavaging device to clinician collection of specimens for cervical cancer screening

21 January 2018

1 reference

Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone

21 January 2018

1 reference

Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract

21 January 2018

1 reference

Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia

21 January 2018

1 reference

Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women

21 January 2018

1 reference

Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection

21 January 2018

1 reference

Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract

21 January 2018

1 reference

Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases

21 January 2018

1 reference

Clinical validation of a real-time polymerase chain reaction detection of Neisseria gonorrheae porA pseudogene versus culture techniques.

21 January 2018

1 reference

Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV.

21 January 2018

1 reference

Vaginal microbicides can interfere with nucleic acid amplification tests used for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infection

21 January 2018

1 reference

Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule

21 January 2018

1 reference

Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy

21 January 2018

1 reference

Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation

21 January 2018

1 reference

Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses

21 January 2018

1 reference

Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.

21 January 2018

1 reference

Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells.

21 January 2018

1 reference

Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes

21 January 2018

1 reference

The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection

21 January 2018

1 reference

Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses

21 January 2018

1 reference

Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses

21 January 2018

1 reference

The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques

21 January 2018

1 reference

Genital secretory immune response to chronic simian immunodeficiency virus (SIV) infection: a comparison between intravenously and genitally inoculated rhesus macaques

21 January 2018

1 reference

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic

21 January 2018

1 reference

A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection

21 January 2018

1 reference

Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques

21 January 2018

1 reference

Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: implications for qualitative research.

21 January 2018

1 reference

Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Côte d'Ivoire

21 January 2018

1 reference

Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.

21 January 2018

1 reference

Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans

21 January 2018

1 reference

HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers

21 January 2018

1 reference

Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition

21 January 2018

1 reference

Quantification of genital human immunodeficiency virus type 1 (HIV-1) DNA in specimens from women with low plasma HIV-1 RNA levels typical of HIV-1 nontransmitters

21 January 2018

1 reference

Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission?

21 January 2018

1 reference

HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women

21 January 2018

1 reference

Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women

21 January 2018

1 reference

Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection

21 January 2018

1 reference

Characterization of baseline intestinal mucosal indices of injury and inflammation in men for use in rectal microbicide trials (HIV Prevention Trials Network-056).

21 January 2018

1 reference

Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.

21 January 2018

1 reference

Isolating mucosal lymphocytes from biopsy tissue for cellular immunology assays

21 January 2018

1 reference

Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines

21 January 2018

1 reference

Parallel human immunodeficiency virus type 1-specific CD8+ T-lymphocyte responses in blood and mucosa during chronic infection

21 January 2018

1 reference

The candidate sulfonated microbicide, PRO 2000, has potential multiple mechanisms of action against HIV-1

21 January 2018

1 reference

Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface

21 January 2018

1 reference

Detection of Mucosal Antibodies in HIV Type 1-Infected Individuals

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.10.21

1 reference

22 August 2017

1 reference